BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9570138)

  • 1. Chromosomal translocations involving paired box transcription factors in human cancer.
    Barr FG
    Int J Biochem Cell Biol; 1997 Dec; 29(12):1449-61. PubMed ID: 9570138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG
    Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.
    Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Pax3 and Pax7 in development and cancer.
    Mansouri A
    Crit Rev Oncog; 1998; 9(2):141-9. PubMed ID: 9973247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.
    Davis RJ; Barr FG
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8047-51. PubMed ID: 9223312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma.
    Barr FG; Nauta LE; Davis RJ; Schäfer BW; Nycum LM; Biegel JA
    Hum Mol Genet; 1996 Jan; 5(1):15-21. PubMed ID: 8789435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusions involving paired box and fork head family transcription factors in the pediatric cancer alveolar rhabdomyosarcoma.
    Barr FG
    Curr Top Microbiol Immunol; 1997; 220():113-29. PubMed ID: 9103678
    [No Abstract]   [Full Text] [Related]  

  • 8. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
    Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
    J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma.
    Bennicelli JL; Advani S; Schäfer BW; Barr FG
    Oncogene; 1999 Jul; 18(30):4348-56. PubMed ID: 10439042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins.
    Bernasconi M; Remppis A; Fredericks WJ; Rauscher FJ; Schäfer BW
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13164-9. PubMed ID: 8917562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
    Anderson J; Gordon T; McManus A; Mapp T; Gould S; Kelsey A; McDowell H; Pinkerton R; Shipley J; Pritchard-Jones K;
    Br J Cancer; 2001 Sep; 85(6):831-5. PubMed ID: 11556833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE; Jeon IS; Shapiro DN
    Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method.
    Kelly KM; Womer RB; Barr FG
    Cancer; 1996 Sep; 78(6):1320-7. PubMed ID: 8826957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma.
    Barr FG
    Cancer Res; 1999 Apr; 59(7 Suppl):1711s-1715s. PubMed ID: 10197585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions.
    Collins MH; Zhao H; Womer RB; Barr FG
    Med Pediatr Oncol; 2001 Aug; 37(2):83-9. PubMed ID: 11496344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells.
    Tiffin N; Williams RD; Shipley J; Pritchard-Jones K
    Br J Cancer; 2003 Jul; 89(2):327-32. PubMed ID: 12865925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of PAX7 rearrangements in alveolar rhabdomyosarcoma.
    Fitzgerald JC; Scherr AM; Barr FG
    Cancer Genet Cytogenet; 2000 Feb; 117(1):37-40. PubMed ID: 10700864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
    Davis RJ; D'Cruz CM; Lovell MA; Biegel JA; Barr FG
    Cancer Res; 1994 Jun; 54(11):2869-72. PubMed ID: 8187070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma.
    Du S; Lawrence EJ; Strzelecki D; Rajput P; Xia SJ; Gottesman DM; Barr FG
    Int J Cancer; 2005 May; 115(1):85-92. PubMed ID: 15688409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes.
    Schäfer BW; Czerny T; Bernasconi M; Genini M; Busslinger M
    Nucleic Acids Res; 1994 Nov; 22(22):4574-82. PubMed ID: 7527137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.